Khorasan Wheat (Kamut®, Triticum turanicum)

Triticum turgidum subsp. turanicum
Evidence Level
Limited
8 Clinical Trials
7 Documented Benefits
2/5 Evidence Score

Khorasan wheat (Triticum turgidum subsp. turanicum) is a tetraploid wheat related to durum and emmer, eaten as whole berries, flour, pasta and bread. Kamut® is a registered trademark for certified organic khorasan wheat, and the brand used in most human trials. It is a true wheat: FDA counts every Triticum species as wheat, a major food allergen, and as a gluten-containing grain, so it is not suitable for people who must avoid wheat or gluten. Per USDA, 100 g of uncooked khorasan has 14.5 g of protein and 11.1 g of fiber. Small randomized trials, most from one research group and partly funded by Kamut Enterprises of Europe, a Kamut trademark holder, found lower cholesterol, glucose and inflammation markers when khorasan products replaced modern wheat products for 4 to 16 weeks; these are blood markers. A blinded trial's registered office blood pressure outcome did not change.

Studied Dose Trials replaced all grain foods with khorasan bread, pasta, crackers and biscuits for 4 to 16 weeks, for example 150 g of bread a day plus 500 g of pasta a week, or about 62 g of semolina and 140 g of flour (dry weight) a day. No supplement dose is established.
Active Compound Whole khorasan grain: mostly starch, with protein including the gluten proteins (gliadins and glutenins) of wheat, dietary fiber, fat, minerals and carotenoids such as lutein. Per USDA, 100 g uncooked khorasan has 337 kcal, 14.5 g protein, 2.13 g fat, 70.6 g carbohydrate (52.4 g starch), 11.1 g fiber, 3.77 mg iron, 130 mg magnesium, 3.68 mg zinc, 2.74 mg manganese, 81.5 µg selenium and 6.38 mg niacin; 100 g cooked has 132 kcal, 5.71 g protein and 4.3 g fiber.

Benefits

Protein, fiber and minerals in whole khorasan grain

Per 100 g uncooked, USDA lists 14.5 g of protein, 11.1 g of fiber, 130 mg of magnesium, 3.8 mg of iron, 3.7 mg of zinc and 81.5 µg of selenium. In a Belgian field comparison, khorasan grain had more protein and ash (a mineral measure) and less total carbohydrate than modern wheat, but the differences in daily intake were small once the grains were baked into bread.

Cholesterol, insulin and glucose when khorasan replaces modern wheat

In 8 week crossover trials in 22 healthy adults and in 21 adults with type 2 diabetes, replacing all grain foods with khorasan products lowered total and LDL cholesterol from baseline, while matched modern wheat products did not. Only the diabetes trial reported a significant between-diet difference, for cholesterol, insulin and insulin resistance. These are blood markers.

Inflammation, oxidative stress and liver enzyme markers

Several small trials reported lower blood cytokines such as TNF-alpha, IL-6 or MCP-1 after khorasan products but not after modern wheat products, in healthy adults, heart patients and young athletes, and lower oxidative stress markers in the first two groups. In 40 adults with fatty liver, liver enzymes fell only in the khorasan group over 3 months. All are blood markers, mostly from one group.

Ambulatory blood pressure and blood vessel reactivity over 4 weeks

In a double-blind crossover trial in 63 adults with high-normal blood pressure, 4 weeks of khorasan foods lowered daytime and night systolic pressure on 24 hour monitoring and improved a blood vessel reactivity measure compared with modern wheat foods. The registered primary outcome, office blood pressure, did not change.

Digestive symptom scores with blinded khorasan and modern wheat foods

In a double-blind crossover trial in 20 adults with moderate irritable bowel syndrome, 6 weeks of khorasan foods reduced pain, bloating and quality of life symptom scores more than modern wheat foods did; on the overall severity score, 14 people responded on khorasan against 5 on modern wheat. The trial was small and not registered, and the results apply to that population.

Pain and daily function questionnaire scores with khorasan foods

In a double-blind crossover trial in 20 adults with fibromyalgia, scores improved during both diet periods, but the impact questionnaire score fell 22.5 percent during 8 weeks of khorasan foods against 0.3 percent with modern wheat foods, a significant difference. The results apply to that population and need repeating in larger trials.

Body fat and fasting insulin in healthy adults over 16 weeks

In an open-label parallel trial in 30 healthy adults, 16 weeks of whole grain khorasan foods led to a greater fall in fat mass and fasting insulin than whole grain durum wheat foods. The khorasan group started with more body fat, and body weight and BMI did not change in either group.

Mechanism of action

1

Gluten proteins and celiac-active peptides

Gluten-specific T cell lines from the small intestine of 13 people with celiac disease reacted to Kamut and to modern and other ancient wheats over wide ranges, so the authors advise avoiding ancient wheats. A review found ancient wheats, including khorasan, hold as much or more gluten and celiac-active gliadin peptides than modern wheat.

2

Grain composition varies with growing site and lot

In one trial's flours, Kamut flour had more protein, amylose, polyphenols, carotenoids and minerals than the control soft wheat flour, while the two semolinas had similar protein, starch and antioxidant content but differed in several minerals. A critical review notes the khorasan and control wheats in these trials were not grown side by side, so mineral and other differences may reflect where the grain was grown.

3

A tetraploid wheat related to emmer and durum

Khorasan wheat is a minor form of the tetraploid (AABB genome) wheat species that also includes emmer and modern durum wheat. Modern bread wheat and spelt are hexaploid. Kamut® is one genotype of khorasan wheat, grown only on certified organic farms under the trademark rules.

Clinical trials

1
Kamut Products vs Semi-Whole Modern Wheat Products for 8 Weeks Each: Lipids, Glucose and Inflammation Markers in Healthy Adults
PubMed

Randomized, single-blinded crossover trial; all grain foods replaced by Kamut or organic semi-whole-grain modern durum and soft wheat products (500 g of pasta a week, 150 g of bread a day, 500 g of crackers and 1 kg of biscuits a month) for 8 weeks each with an 8 week washout; no registration number found in the full text; supported in part by a grant from Kamut Enterprise of Europe (KEE), authors declared no conflict of interest (Sofi et al. 2013, Eur J Clin Nutr)

22 healthy adults (14 women, 8 men) in Florence, Italy.

After the Kamut phase, total cholesterol fell 8.46 mg/dl (4 percent), LDL cholesterol 9.82 mg/dl (7.8 percent), and blood glucose, oxidative stress markers and cytokines (IL-6, IL-12, TNF-alpha, VEGF) also fell, while serum potassium and magnesium rose; changes after the control phase were not significant. Results are reported mainly as changes from baseline within each phase.

2
Khorasan vs Modern Wheat Products for 6 Weeks Each: Symptom Scores in Irritable Bowel Syndrome
PubMed

Randomized, double-blinded crossover trial; bread, pasta, biscuits and crackers from organic semi-whole khorasan wheat (given by Kamut International) or modern wheat for 6 weeks each with a 6 week washout; symptoms by IBS-GAI and IBS-SSS questionnaires; no registration number found in the full text; partly financed by Kamut Enterprise of Europe, which had no role in design, analysis or writing (Sofi et al. 2014, Br J Nutr)

20 adults aged 18 to 59 (13 women) with moderate irritable bowel syndrome (mean IBS-SSS 237) in Florence, Italy.

Abdominal pain, bloating, stool satisfaction, tiredness and quality of life scores improved significantly during the khorasan phase only; on the IBS-SSS total score, 14 participants (70 percent) were responders after khorasan against 5 (25 percent) after modern wheat, end-of-period scores were 162 against 230 (P < 0.005), and symptom changes differed significantly from the modern wheat period (P < 0.05). IL-6, IL-17, interferon-gamma, MCP-1 and VEGF fell after khorasan only. Small, single-center trial; symptom scores in a diagnosed population.

3
Organic Khorasan vs Organic Modern Wheat Products for 8 Weeks Each: Lipid, Oxidative and Inflammatory Markers in Heart Patients
PubMed

Randomized, double-blinded crossover trial; bread, pasta, biscuits and crackers from organic semi-whole khorasan (provided by Kamut Enterprise of Europe) or control wheat for 8 weeks each with an 8 week washout, on average 62.0 g of semolina and 140.5 g of flour (dry weight) a day; no registration number found in the full text; sponsored in part by a KEE grant, authors declared no conflict of interest (Whittaker et al. 2015, Nutrients)

22 adults (9 women, 13 men) with acute coronary syndrome on standard drug therapy, Florence, Italy.

From baseline, the khorasan phase lowered total cholesterol 6.8 percent, LDL cholesterol 8.1 percent, glucose 8 percent and insulin 24.6 percent, with lower reactive oxygen species and TNF-alpha; no significant changes from baseline after the control phase. Results are reported as within-phase changes; no clinical events were measured.

4
Khorasan vs Modern Wheat Products for 8 Weeks Each: Cholesterol, Insulin and Glucose in Type 2 Diabetes
PubMed

Randomized, double-blinded crossover trial; pasta (500 g a week), bread (150 g a day), crackers and biscuits (250 g a week each) from organic semi-whole Kamut® khorasan (provided by Kamut Enterprises of Europe) or modern wheat for 8 weeks each with an 8 week washout, replacing about 722 kcal a day; no registration number found in the full text; supported in part by a KEE grant, conflict of interest none (Whittaker et al. 2017, Eur J Nutr)

21 adults (14 women, 7 men) with type 2 diabetes, Florence, Italy.

After khorasan, total and LDL cholesterol fell 3.7 and 3.4 percent, insulin 16.3 percent and glucose 9.1 percent, with lower reactive oxygen species and higher antioxidant capacity; no significant changes after modern wheat. The between-arm change differed significantly (p < 0.05) for total and LDL cholesterol, insulin and HOMA index.

5
Kamut® Khorasan vs Modern Wheat Products for 3 Months: Liver Enzymes in Fatty Liver Disease
PubMed

Randomized, double-blind, parallel-arm trial; pasta, bread, crackers and biscuits from Kamut khorasan or organic semi-whole-grain modern wheat for 3 months; no registration number in the abstract and none found on ClinicalTrials.gov; Europe PMC lists Kamut Enterprises of Europe (KEE) as the grant agency (Dinu et al. 2018, J Am Coll Nutr)

40 adults (28 women, mean age 55) with mild to moderate nonalcoholic fatty liver disease, 20 per group, Florence, Italy.

Only in the khorasan group, ALT fell 12 percent, AST 14 percent, alkaline phosphatase 8 percent and cholesterol 6 percent, with lower TNF-alpha, IL-8 and interferon-gamma (p < 0.05). Liver steatosis grade, Doppler perfusion index and reactive oxygen species improved in both groups.

6
Kamut® Khorasan vs Modern Durum and Soft Wheat Foods for 4 Weeks Each: Blood Pressure and Vessel Function (registered primary null)
PubMed

Double-blind, randomized, feeding-controlled crossover trial; pasta, bread and crisp toasts of organic Kamut khorasan or organic modern durum and soft wheat, same look and taste, for 4 weeks each with a 4 week washout after a 4 week standardized diet; registered NCT02197910 (sponsor University of Bologna) with office blood pressure as the primary outcome, while the paper powered the study on endothelial reactivity; funded by the EU 7th Framework Programme BACCHUS, products provided by Kamut Enterprises of Europe, no conflicts declared (Cicero et al. 2018, Nutrients)

63 adults aged 40 to 70 without diabetes with high-normal blood pressure (30 men, 33 women) in Bologna, Italy; all completed.

Office blood pressure did not change. With khorasan foods, daytime ambulatory systolic pressure was 132.4 against 136.3 mmHg with modern wheat and night systolic 116.4 against 120.8 mmHg, and pulse volume change rose to 68.1 against 64.3 percent (p < 0.05); triglycerides and fasting glucose also improved, while pulse wave velocity did not change. Some percentages in the text do not match the table values, and diaries showed a lower carbohydrate share of energy during the khorasan phase. No adverse effects were reported.

7
Whole Grain Kamut® Khorasan vs Whole Grain Durum Wheat Products for 16 Weeks: Body Fat and Insulin in Healthy Adults
PubMed

Randomized, non-blind, parallel-arm pilot study; whole grain organic Kamut khorasan or modern durum wheat bread, biscuits, pasta, crackers and crisp toasts as the only cereal source 6 days a week for 16 weeks; no registration number found in the full text; supported in part by a grant from Kamut Enterprises of Europe; authors from the testing laboratories Bioaesis srl and Biomedfood srl, no conflict of interest declared (Trozzi et al. 2019, Eur J Nutr)

30 healthy adults aged 25 to 60 in Jesi, Italy, 15 per group; all completed.

Compared with baseline in quantile regression, the khorasan group had a greater fall in fat mass (b = 3.7 percent, p = 0.042) and fasting insulin (b = 2.4 µU/ml, p = 0.036) and a rise in blood DHA. The khorasan group had higher fat mass at baseline (p = 0.019), and body weight, BMI and blood pressure did not change in either group.

8
Khorasan vs Modern Wheat Products for 8 Weeks Each: Symptom Questionnaires in Fibromyalgia
PubMed

Randomized, double-blinded crossover trial; pasta, bread, crackers and biscuits from khorasan or organic semi-whole-grain modern wheat for 8 weeks each; validated self-administered questionnaires; no registration number in the abstract and none found on ClinicalTrials.gov; Europe PMC lists Kamut Enterprise of Europe as the grant agency (Pagliai et al. 2020, Pain Med)

20 adults (19 women, mean age 48.9) with fibromyalgia, Florence, Italy.

Scores improved after both periods, more after khorasan: Widespread Pain Index plus Severity Scale fell 21.5 percent and the sleep questionnaire score changed 11.7 percent only after khorasan, and the FM Impact Questionnaire fell 22.5 percent against 0.3 percent with control wheat (P = 0.037 between periods). Symptom scores in a diagnosed population.

Side effects and drug interactions

Common Potential side effects

Gluten: khorasan is a wheat and contains gluten. FDA's gluten-free rule counts any species of the genus Triticum as a gluten-containing grain, and gluten-specific T cells from people with celiac disease reacted to Kamut in lab tests. People who must avoid gluten should not eat khorasan or Kamut® products.
Wheat allergy: FDA allergen guidance names Khorasan as wheat, a major food allergen that must be declared as wheat on labels. People with wheat allergy should not use khorasan as a substitute for modern wheat.
Trial reports: compliance was described as good in the 16 week trial and almost total in the 4 week trial of 63 people, which reported no adverse effects; the other trials read did not describe side effects in detail.
Fiber: whole khorasan grain has about 11 g of fiber per 100 g uncooked. Increase whole grain intake gradually if you are not used to it.

Important Drug interactions

Diabetes medicines: in a trial in adults with type 2 diabetes, insulin and blood glucose fell when khorasan products replaced modern wheat products. Check blood sugar when changing the main grain in your diet and tell your prescriber.
No drug interaction studies of khorasan grain or flour were found. Tell your doctor or pharmacist about any concentrated khorasan extract or bran product you take.

Frequently asked questions about Khorasan Wheat (Kamut®, Triticum turanicum)

Is khorasan wheat the same as Kamut?

Kamut® is a registered trademark (of Kamut International, Ltd. and Kamut Enterprises of Europe, as stated in trial papers) for one genotype of khorasan wheat that is always grown certified organic. Khorasan wheat sold without the trademark is the same species, Triticum turgidum subsp. turanicum, but it may be a different line grown under different rules.

Does khorasan wheat contain gluten?

Yes. FDA treats any species of the genus Triticum as a gluten-containing grain and names Khorasan as wheat for allergen labeling. In lab tests, gluten-specific T cells from people with celiac disease reacted to Kamut as well as to modern and other ancient wheats, and reviews find ancient wheats carry as much or more celiac-active gluten. It is not gluten-free.

Is khorasan easier on digestion than modern wheat?

One small blinded trial in 20 adults with irritable bowel syndrome found better symptom scores with khorasan foods than with modern wheat foods over 6 weeks, with 14 responders against 5 on the overall severity score. It was not registered, was run by one research group and was partly funded by Kamut Enterprises of Europe, a Kamut trademark holder. Larger independent trials are needed.

What did trials find on cholesterol and blood sugar?

In small crossover trials, total and LDL cholesterol, glucose and insulin fell after 8 weeks of khorasan products but not after matched modern wheat products. For cholesterol and insulin, only one trial, in 21 adults with type 2 diabetes, reported a significant between-diet difference; a 4 week blood pressure trial also found lower fasting glucose and triglycerides than with modern wheat. These are blood markers, and no trial measured heart events.

How does khorasan compare with modern wheat in nutrients?

Per 100 g uncooked, USDA lists 14.5 g of protein and 11.1 g of fiber for khorasan. In field and trial analyses it had more protein and minerals than modern wheat, but growing site strongly changes mineral content, and once baked into bread the differences in daily intake were small.

What is Khorasan Wheat?

Khorasan wheat (Triticum turgidum subsp. turanicum) is a tetraploid wheat related to durum and emmer, eaten as whole berries, flour, pasta and bread. Kamut® is a registered trademark for certified organic khorasan wheat, and the brand used in most human trials.

What is Khorasan Wheat used for?

NutraSmarts does not list Khorasan Wheat under a health category. What the research covers: Per 100 g uncooked, USDA lists 14.5 g of protein, 11.1 g of fiber, 130 mg of magnesium, 3.8 mg of iron, 3.7 mg of zinc and 81.5 µg of selenium.

What is the recommended dosage of Khorasan Wheat?

The clinically studied dose is Trials replaced all grain foods with khorasan bread, pasta, crackers and biscuits for 4 to 16 weeks, for example 150 g of bread a day plus 500 g of pasta a week, or about 62 g of semolina and 140 g of flour (dry weight) a day. Always follow the product label and check with a healthcare provider for personal advice.

Is Khorasan Wheat safe, and does it have side effects?

Side effects and cautions reported for Khorasan Wheat include: Gluten: khorasan is a wheat and contains gluten. FDA's gluten-free rule counts any species of the genus Triticum as a gluten-containing grain, and gluten-specific T cells from people with celiac disease reacted to Kamut in lab tests. It may also interact with some medications. Khorasan Wheat is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Khorasan Wheat interact with any medications?

Possible interactions include: Diabetes medicines: in a trial in adults with type 2 diabetes, insulin and blood glucose fell when khorasan products replaced modern wheat products. Check blood sugar when changing the main grain in your diet and tell your prescriber. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Khorasan Wheat?

NutraSmarts rates the evidence for Khorasan Wheat as Limited (2 out of 5). It is backed by 8 study summaries and 16 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(16 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Sofi F, Whittaker A, Cesari F, Gori AM, Fiorillo C, Becatti M, Marotti I, Dinelli G, Casini A, Abbate R, Gensini GF, Benedettelli S. Characterization of Khorasan wheat (Kamut) and impact of a replacement diet on cardiovascular risk factors: cross-over dietary intervention study. Eur J Clin Nutr. 2013;67(2):190-5. doi: 10.1038/ejcn.2012.206.PubMedUsed to support: Randomized, single-blinded crossover trial in 22 healthy adults: Kamut or control semi-whole-grain wheat products for 8 weeks each. After Kamut, total cholesterol fell 8.46 mg/dl (4 percent), LDL cholesterol 9.82 mg/dl (7.8 percent), and glucose, TBARS, carbonyls and IL-6, IL-12, TNF-alpha and VEGF fell, with higher potassium and magnesium; control phase changes were not significant. Kamut flour had more protein, amylose, polyphenols and minerals than control flour. Supported in part by a Kamut Enterprise of Europe grant; no conflict of interest declared.
  2. Sofi F, Whittaker A, Gori AM, Cesari F, Surrenti E, Abbate R, Gensini GF, Benedettelli S, Casini A. Effect of Triticum turgidum subsp. turanicum wheat on irritable bowel syndrome: a double-blinded randomised dietary intervention trial. Br J Nutr. 2014;111(11):1992-9. doi: 10.1017/S000711451400018X.PubMedUsed to support: Randomized, double-blinded crossover trial in 20 adults with moderate IBS: khorasan or modern wheat bread, pasta, biscuits and crackers for 6 weeks each. Symptom scores (pain, bloating, stool satisfaction, tiredness, quality of life) improved after khorasan only, with 14 against 5 responders on the IBS-SSS total score and between-period differences (P < 0.05), and IL-6, IL-17, interferon-gamma, MCP-1 and VEGF fell after khorasan only. Wheat given by Kamut International; partly financed by Kamut Enterprise of Europe, which had no role in design or analysis.
  3. Whittaker A, Sofi F, Luisi ML, Rafanelli E, Fiorillo C, Becatti M, Abbate R, Casini A, Gensini GF, Benedettelli S. An organic khorasan wheat-based replacement diet improves risk profile of patients with acute coronary syndrome: a randomized crossover trial. Nutrients. 2015;7(5):3401-15. doi: 10.3390/nu7053401.PubMedUsed to support: Randomized, double-blinded crossover trial in 22 adults with acute coronary syndrome: organic semi-whole khorasan or control wheat products for 8 weeks each (about 62 g semolina and 140.5 g flour dry weight a day). From baseline, khorasan lowered total cholesterol 6.8 percent, LDL 8.1 percent, glucose 8 percent and insulin 24.6 percent, plus ROS and TNF-alpha; no changes after control wheat. Wheat provided by and study sponsored in part by Kamut Enterprise of Europe; no conflict of interest declared.
  4. Whittaker A, Dinu M, Cesari F, Gori AM, Fiorillo C, Becatti M, Casini A, Marcucci R, Benedettelli S, Sofi F. A khorasan wheat-based replacement diet improves risk profile of patients with type 2 diabetes mellitus (T2DM): a randomized crossover trial. Eur J Nutr. 2017;56(3):1191-1200. doi: 10.1007/s00394-016-1168-2.PubMedUsed to support: Randomized, double-blinded crossover trial in 21 adults with type 2 diabetes: organic Kamut khorasan or modern wheat products for 8 weeks each. After khorasan, total and LDL cholesterol fell 3.7 and 3.4 percent, insulin 16.3 percent and glucose 9.1 percent; between-arm changes differed significantly for total and LDL cholesterol, insulin and HOMA. States KAMUT® is a registered trademark of Kamut International, Ltd. and Kamut Enterprises of Europe, bvba. Supported in part by a KEE grant; conflict of interest none.
  5. Dinu M, Whittaker A, Pagliai G, Giangrandi I, Colombini B, Gori AM, Fiorillo C, Becatti M, Casini A, Benedettelli S, Sofi F. A Khorasan Wheat-Based Replacement Diet Improves Risk Profile of Patients With Nonalcoholic Fatty Liver Disease (NAFLD): A Randomized Clinical Trial. J Am Coll Nutr. 2018;37(6):508-514. doi: 10.1080/07315724.2018.1445047.PubMedUsed to support: Randomized, double-blind, parallel-arm trial in 40 adults with NAFLD: Kamut khorasan or modern semi-whole-grain wheat products for 3 months. ALT (-12 percent), AST (-14 percent), ALP (-8 percent), cholesterol (-6 percent) and TNF-alpha, IL-1ra, IL-8 and interferon-gamma fell only with khorasan; steatosis grade and ROS improved with both. Europe PMC lists Kamut Enterprises of Europe (KEE) as grant agency.
  6. Cicero AFG, Fogacci F, Veronesi M, Grandi E, Dinelli G, Hrelia S, Borghi C. Short-Term Hemodynamic Effects of Modern Wheat Products Substitution in Diet with Ancient Wheat Products: A Cross-Over, Randomized Clinical Trial. Nutrients. 2018;10(11):1666. doi: 10.3390/nu10111666.PubMedUsed to support: Double-blind, randomized crossover trial (NCT02197910) in 63 adults with high-normal blood pressure: Kamut khorasan or modern durum and soft wheat pasta, bread and crisp toasts for 4 weeks each. Office blood pressure (the registered primary) did not change; daytime and night ambulatory systolic pressure, pulse volume change, triglycerides and fasting glucose improved versus modern wheat. Funded by the EU FP7 BACCHUS project; products provided by Kamut Enterprises of Europe; no conflicts declared.
  7. Trozzi C, Raffaelli F, Vignini A, Nanetti L, Gesuita R, Mazzanti L. Evaluation of antioxidative and diabetes-preventive properties of an ancient grain, KAMUT(®) khorasan wheat, in healthy volunteers. Eur J Nutr. 2019;58(1):151-161. doi: 10.1007/s00394-017-1579-8.PubMedUsed to support: Randomized, non-blind, parallel-arm pilot study in 30 healthy adults: whole grain Kamut khorasan or modern durum wheat products as the only cereal source for 16 weeks. Khorasan led to greater falls in fat mass and insulin and a rise in DHA; the khorasan group had higher baseline fat mass, and weight and BMI did not change. Supported in part by Kamut Enterprises of Europe; authors from Bioaesis srl and Biomedfood srl; no conflict of interest declared.
  8. Pagliai G, Colombini B, Dinu M, Whittaker A, Masoni A, Danza G, Amedei A, Ballerini G, Benedettelli S, Sofi F. Effectiveness of a Khorasan Wheat-Based Replacement on Pain Symptoms and Quality of Life in Patients with Fibromyalgia. Pain Med. 2020;21(10):2366-2372. doi: 10.1093/pm/pnaa134.PubMedUsed to support: Randomized, double-blinded crossover trial in 20 adults with fibromyalgia: khorasan or modern semi-whole-grain wheat products for 8 weeks each. Questionnaire scores improved after both periods, more after khorasan; the FM Impact Questionnaire fell 22.5 percent against 0.3 percent (P = 0.037). Europe PMC lists Kamut Enterprise of Europe as grant agency.
  9. Spisni E, Valerii MC, De Fazio L, Rotondo E, Di Natale M, Giovanardi E, Posabella G, Bregola V, Stenico V, Sferrazza RE, Dinelli G, Bosi S. A Khorasan wheat-based diet improves systemic inflammatory profile in semi-professional basketball players: a randomized crossover pilot study. J Sci Food Agric. 2020;100(11):4101-4107. doi: 10.1002/jsfa.9947.PubMedUsed to support: Randomized, single-blinded crossover pilot study in 20 young male basketball players: Kamut khorasan or modern semi-whole-grain wheat pasta, bread, biscuits and crackers for 4 weeks each. MCP-1 fell 25.67 percent and self-rated health improved with khorasan; no athletic performance measure differed between diets. Europe PMC lists Kamut Enterprises of Europe (KEE) and the University of Bologna as grant agencies.
  10. Shewry PR. Do ancient types of wheat have health benefits compared with modern bread wheat? J Cereal Sci. 2018;79:469-476. doi: 10.1016/j.jcs.2017.11.010.PubMedUsed to support: Critical review of ancient versus modern wheat health studies. Six trials compared Kamut or related khorasan with modern wheats, but none grew Kamut in identical conditions to the control wheats, so composition differences may reflect growing sites. Notes Kamut is a registered trademark of Kamut International Ltd, grown only on certified organic farms, and calls for studies from more research groups and more genotypes.
  11. Brouns F, Geisslitz S, Guzman C, Ikeda TM, Arzani A, Latella G, Simsek S, Colomba M, Gregorini A, Zevallos V, Lullien-Pellerin V, Jonkers D, Shewry PR. Do ancient wheats contain less gluten than modern bread wheat, in favour of better health? Nutr Bull. 2022;47(2):157-167. doi: 10.1111/nbu.12551.PubMedUsed to support: Critical narrative review: gluten is present in all wheats, including einkorn, emmer, spelt and Khorasan, and all can induce celiac disease in susceptible people. Ancient wheats contain more protein and gluten and more celiac-active epitopes than bread wheat; khorasan is a tetraploid (AABB) wheat, a minor form of the species that includes emmer and durum. No single wheat type can be recommended for celiac disease.
  12. Šuligoj T, Gregorini A, Colomba M, Ellis HJ, Ciclitira PJ. Evaluation of the safety of ancient strains of wheat in coeliac disease reveals heterogeneous small intestinal T cell responses suggestive of coeliac toxicity. Clin Nutr. 2013;32(6):1043-9. doi: 10.1016/j.clnu.2013.02.003.PubMedUsed to support: Laboratory study: small intestinal gluten-specific T cell lines from 13 people with celiac disease were tested against seven wheat accessions including Kamut. All wheats, ancient or modern, triggered heterogeneous T cell responses, and the authors advise strict avoidance of ancient wheats in celiac disease.
  13. Van Boxstael F, Aerts H, Linssen S, Latré J, Christiaens A, Haesaert G, Dierickx I, Brusselle J, De Keyzer W. A comparison of the nutritional value of Einkorn, Emmer, Khorasan and modern wheat: whole grains, processed in bread, and population-level intake implications. J Sci Food Agric. 2020;100(11):4108-4118. doi: 10.1002/jsfa.10402.PubMedUsed to support: Composition analysis of Belgian-grown einkorn, emmer, khorasan and modern wheat grains and breads. Ancient wheats including khorasan had lower total carbohydrate and higher protein and ash than modern wheat; khorasan bread had lower vitamin E but higher total phenols than modern wheat bread. Replacing modern wheat bread changed population nutrient intakes very little.
  14. U.S. Department of Agriculture, Agricultural Research Service. FoodData Central: Wheat, khorasan, uncooked (SR Legacy, FDC ID 169743). USDA FoodData Central. 2019;SR Legacy food 20138; cooked khorasan is FDC ID 169744 (NDB 20139)..SourceUsed to support: Not PubMed-indexed; USDA nutrient database entry read via FoodData Central (Triticum turgidum subsp. turanicum). Per 100 g uncooked khorasan: 337 kcal, 14.5 g protein, 2.13 g fat, 70.6 g carbohydrate, 52.4 g starch, 11.1 g fiber, 3.77 mg iron, 130 mg magnesium, 3.68 mg zinc, 2.74 mg manganese, 81.5 µg selenium and 6.38 mg niacin; 1 cup weighs 186 g. Per 100 g cooked: 132 kcal, 5.71 g protein, 4.3 g fiber; 1 cup weighs 172 g.
  15. U.S. Food and Drug Administration (Code of Federal Regulations, read 2026). 21 CFR 101.91 Gluten-free labeling of food. Electronic Code of Federal Regulations. 2026;Title 21, Part 101, Subpart F, Section 101.91..SourceUsed to support: Not PubMed-indexed; US federal regulation read via the eCFR API. Defines a gluten-containing grain as wheat (including any species belonging to the genus Triticum), rye or barley or their crossbred hybrids, and a gluten-free food as one without a gluten-containing grain ingredient (e.g., spelt wheat) and with less than 20 ppm gluten.
  16. U.S. Food and Drug Administration. Questions and Answers Regarding Food Allergens, Including the Food Allergen Labeling Requirements of the Federal Food, Drug, and Cosmetic Act (Edition 5): Guidance for Industry. FDA Guidance for Industry. 2025;Edition 5, January 2025; question C.9..SourceUsed to support: Not PubMed-indexed; FDA guidance read in full text. Answer C.9 states that for the major food allergen definition, wheat means any species in the genus Triticum, and lists Khorasan with common, durum, club, spelt, einkorn and emmer wheat, semolina and triticale. The guidance gives Khorasan the botanical name Triticum polonicum L., while USDA uses Triticum turgidum subsp. turanicum.